Clinical Trials Browser

Phase 1 × anetumab ravtansine × Clear all

NCT03455556 2023-01-06

Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer

Phase 1 Terminated

1 enrolled 1 chart

Carcinoma, Non-Small-Cell Lung

NCT03102320 2022-06-30

ARCS-Multi

Phase 1 Completed

BreastGastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms, Pancreatic Neoplasms, Thymoma, Cholangiocarcinoma, Triple Negative Breast Neoplasms

NCT02696642 2021-07-09

Phase I Study of Anetumab Ravtansine in Hepatic or Renal Impairment

Phase 1 Completed

Neoplasms

NCT02824042 2020-07-31

Thorough ECG (Electrocardiogram) and Drug Interaction Study With Anetumab Ravtansine and Itraconazole

Phase 1 Completed

Medical Oncology

NCT02751918 2019-11-22

Phase Ib Study of Anetumab Ravtansine in Combination With Pegylated Liposomal Doxorubicin in Patients With Recurrent Mesothelin-expressing Platinum-resistant Cancer

Phase 1 Completed

Ovarian Neoplasms

NCT02639091 2019-11-07

Phase Ib Study of Anetumab Ravtansine in Combination With Pemetrexed and Cisplatin in Mesothelin-expressing Solid Tumors

Phase 1 Completed

Other solid neoplasmThoracic

Lung Neoplasms, Mesothelioma